https://www.gosh.nhs.uk/news/deconstruction-of-the-frontage-building-starting/

Deconstruction of the Frontage Building starting

14 Feb 2025, 9 a.m.

A photograph showing scaffolding and sheeting around the frontage building

We are pleased to announce that deconstruction of the Frontage Building will start on Monday 17 February.

This is a major step forward and means we are nearer to realising our ambition to provide a new home for cancer services, as well as more space for our school, imaging, critical care and theatre services and an amazing new entrance for the whole hospital.

The deconstruction process will be managed carefully by our contractor Sisk and the works will be overseen by the GOSH CCC team.

Information for visitors to GOSH

While it is exciting that we are developing this amazing new facility, we know that this activity may make things feel different for visitors to the hospital.

From your ward window you may be able to see the deconstruction site and works on site. There may be noise at times, but please note there are quiet periods during the day when the sound limits are lower.

These times are:

  • 7am - 8am
  • 12pm - 1pm
  • 5pm - 6pm.

There are maximum limits at all times and no work takes place after 6pm Monday-Friday, or after 1pm on Saturdays.

Please talk to your ward team if the work is disturbing you or you have any concerns.

Thank you for bearing with us as we develop the new building. Contact us if you have any questions or concerns:
Email: ccc@gosh.nhs.uk

Find out more about the Children's Cancer Centre, including how we are managing the deconstruction process.

Surgeon who saved children’s sight surprised by patients, family and colleagues

Professor Chris Lloyd, consultant ophthalmic surgeon and paediatric ophthalmologist, was given a surprise to remember as a part of the BBC The One Show’s ‘One Big Thank You’.

Gentler treatment eliminates early deaths for children with relapsed leukaemia

A groundbreaking national study led by clinicians at Great Ormond Street Hospital (GOSH) has shown that children and young people with relapsed acute lymphoblastic leukaemia (ALL) can be treated safely with significantly less intensive chemotherapy.

NHS eye gene therapy restores Saffie's sight

Saffie has had her sight restored thanks to life-changing eye gene therapy for rare blindness at GOSH

£3M study led by patient voices targets pain in inflammatory arthritis

A new £3 million research programme involving Great Ormond Street Hospital and University College London researchers aims to tackle one of the largest unmet clinical needs in inflammatory arthritis – pain reduction.